CAS NO: | 69049-74-7 |
包装 | 价格(元) |
100mg | 电议 |
250mg | 电议 |
500mg | 电议 |
生物活性 | Nedocromil sodium suppresses the action or formation of multiple mediators, includinghistamine,leukotriene C4(LTC4), andprostaglandin D2(PGD2). | ||||||||||||||||
IC50& Target[1] |
| ||||||||||||||||
体外研究 (In Vitro) | Nedocromil inhibits the release of histamine, LTC4, and PGD2from mast cells challenged with antigen (with IC30values of 2.1 μM, 2.3 μM, and 1.9 μM, respectively) and with anti-human IgE (IC30values of 4.7 μM, 1.3 μM, and 1.3 μM, respectively)[1]. | ||||||||||||||||
体内研究 (In Vivo) | Nedocromil-treated diabetic mice show significantly improved heart function compared with controls. The contractility and relaxation forces show similar improvements. However, the cardiac function of Nedocromil-treated diabetic mice remains significantly impaired when compared with normal mice. Nedocromil can significantly improve cardiac function in mice with diabetic cardiomyopathy, but the treatment cannot restore normal function[2]. | ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 415.30 | ||||||||||||||||
Formula | C19H15NNa2O7 | ||||||||||||||||
CAS 号 | 69049-74-7 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. | ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 5.2 mg/mL(12.52 mM;Need ultrasonic) 配制储备液
In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|